Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWNASDAQ:DHAIWNASDAQ:EAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.10-14.0%$0.12$0.03▼$0.37N/AN/A18,487 shs566 shsBBLGWBone Biologics$13.50$16.00$3.00▼$95.04N/AN/A2,005 shs19 shsDHAIWDIH Holding US$0.01$0.01$0.01▼$0.13N/AN/A138,516 shs9,099 shsEAREargo$70.50$52.85$1.47▼$8.48$1.46B1.523,347 shsN/AA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos0.00%-7.11%-36.20%-48.28%+42.24%BBLGWBone Biologics0.00%0.00%0.00%-33.17%-67.56%DHAIWDIH Holding US0.00%-11.92%-11.92%-30.00%-74.27%EAREargo0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AN/AN/AN/AN/AN/AEAREargoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ADHAIWDIH Holding US 0.00N/AN/AN/AEAREargo 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$106.21KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ADHAIWDIH Holding US$64.47MN/AN/AN/AN/AN/AEAREargo$41.11M35.61N/AN/A$4.87 per share14.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/A0.00∞N/AN/AN/AN/AN/AEAREargo-$157.49M-$7.52N/A∞N/A-263.14%-135.08%-96.37%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AN/AN/AEAREargoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIMDWAinosN/AN/AN/ABBLGWBone BiologicsN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AEAREargoN/A3.222.97Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ADHAIWDIH Holding USN/AEAREargo80.53%Insider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ADHAIWDIH Holding USN/AEAREargo0.81%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableDHAIWDIH Holding USN/AN/AN/AN/AEAREargo24320.76 million20.59 millionNot OptionableEAR, AIMDW, BBLGW, and DHAIW HeadlinesRecent News About These CompaniesReview: Eargo 8 Hearing AidsMay 15, 2025 | wired.comHearing Wellness Pioneer Eargo Launches Eargo 8 As Its Newest Flagship Hearing AidMay 13, 2025 | finance.yahoo.comTiny Eargo 8 Hearing Aids Scan for Issues Messing With Sound Quality (Like Earwax)May 13, 2025 | msn.comHow to sign up to Self Sufficient Culture Forum Tutorial (XenForo)May 12, 2025 | msn.comEargo, Hearx merge into one OTC hearing aid firm, receive $100M boostApril 4, 2025 | finance.yahoo.comEargo and hearX Close Merger, Announce New Combined Company, LXE HearingMarch 31, 2025 | finance.yahoo.comThe Ninth Circuit Affirms Dismissal Of Claims Against Hearing Aid Manufacturer Regarding Statements About Insurance CoverageJanuary 31, 2025 | jdsupra.comFederal Appeals Court Won't Revive Eargo Investor Insurance SuitJanuary 10, 2025 | news.bloomberglaw.comBest Multivitamins For Men In 2024, According To Nutrition ExpertsNovember 14, 2024 | forbes.comAirPods Pro 2 Now Double As Hearing Aids? Here’s What To KnowNovember 9, 2024 | forbes.comHearing Aid Devices Market, Competitive Landscape and Market Forecast to 2030November 7, 2024 | uk.finance.yahoo.comThe 2024 Esquire Gadget AwardsOctober 30, 2024 | msn.comBest Online Hearing TestsOctober 26, 2024 | usnews.comThe Hearing Aid Revolution That Wasn’tOctober 5, 2024 | msn.comU.S. Hearing Aids Market Analysis 2024-2030: Adoption Expected to Rise with FDA's New Over-the-Counter GuidelinesOctober 4, 2024 | uk.finance.yahoo.comBest Waterproof Hearing AidsOctober 4, 2024 | usnews.com8 Best Over-The-Counter Hearing Aids, According To AudiologistsOctober 2, 2024 | menshealth.comAudiologists Say These Are the Best Over-The-Counter Hearing AidsOctober 2, 2024 | aol.comWill the AirPods Pro 2 Make Good Hearing Aids?September 24, 2024 | techlicious.comReview: Sony's New CRE-C20 Are the Best OTC Hearing Aids I've TestedSeptember 24, 2024 | techlicious.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings3 Companies to Buy on This Early Cycle RecoveryBy Gabriel Osorio-Mazilli | June 3, 2025View 3 Companies to Buy on This Early Cycle Recovery3 Stocks Getting Rare Double Upgrades From AnalystsBy Chris Markoch | June 6, 2025View 3 Stocks Getting Rare Double Upgrades From AnalystsSuper Micro Computer Stock Clears New Path Higher on Saudi OrdersBy Gabriel Osorio-Mazilli | May 22, 2025View Super Micro Computer Stock Clears New Path Higher on Saudi OrdersNuclear Stocks Reach Critical Mass: The Time to Buy Is NowBy Thomas Hughes | May 27, 2025View Nuclear Stocks Reach Critical Mass: The Time to Buy Is NowEAR, AIMDW, BBLGW, and DHAIW Company DescriptionsAinos NASDAQ:AIMDW$0.10 -0.02 (-14.04%) As of 06/13/2025 12:22 PM EasternAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$13.50 0.00 (0.00%) As of 06/13/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.DIH Holding US NASDAQ:DHAIW$0.01 0.00 (0.00%) As of 06/13/2025 03:43 PM EasternDIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider in the rehabilitation industry. The company's upper extremity product categories include ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, a sensor-based solution for arm function recovery. It also provides lower extremity product categories comprising Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, an Computer Assisted Rehabilitation Environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, the company offers M-Gait, a modular treadmill system; SafeGait, a balance and mobility trainer; and RYSEN, an 3D bodyweight supporter, as well as software products consist of D-Flow and HocoNet. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Eargo NASDAQ:EAREargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
